Natural Compounds as New Cancer Treatments

Cancer remains one of the main causes of morbidity and mortality worldwide. Although many pharmacological and clinical advances have been made, there is a constant need for new molecules to improve the overall options for treatment. Natural compounds from animal, microbial, vegetal, or fungal origin...

Full description

Saved in:
Bibliographic Details
Main Author: Barrajon, Enrique (auth)
Format: Book Chapter
Published: MDPI - Multidisciplinary Digital Publishing Institute 2019
Subjects:
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02920naaaa2200745uu 4500
001 doab_20_500_12854_54350
005 20210211
020 |a books978-3-03921-366-5 
020 |a 9783039213658 
020 |a 9783039213665 
024 7 |a 10.3390/books978-3-03921-366-5  |c doi 
041 0 |a English 
042 |a dc 
100 1 |a Barrajon, Enrique  |4 auth 
245 1 0 |a Natural Compounds as New Cancer Treatments 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2019 
300 |a 1 electronic resource (128 p.) 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Cancer remains one of the main causes of morbidity and mortality worldwide. Although many pharmacological and clinical advances have been made, there is a constant need for new molecules to improve the overall options for treatment. Natural compounds from animal, microbial, vegetal, or fungal origin represent countless sources of new compounds that can be used as anticancer drugs, provided their activity, bioavailability, and toxicity are adequate. This book aims to compile both original articles and reviews that cover the most recent advances in the use of natural compounds for cancer treatment, and provide new objectives and advice for future research in the field of biological activity of natural compounds. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by-nc-nd/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ 
546 |a English 
653 |a microbiota 
653 |a treatment 
653 |a n/a 
653 |a sulforaphane 
653 |a synergy 
653 |a epigenetic 
653 |a natural compound 
653 |a xenohormesis 
653 |a anticancer 
653 |a miR-663 
653 |a tyrosine kinase inhibitors 
653 |a acetylation 
653 |a epidemiology 
653 |a double-blinded 
653 |a inflammation 
653 |a bladder cancer 
653 |a polypharmacology 
653 |a animal model 
653 |a synbiotics 
653 |a resveratrol 
653 |a royal jelly 
653 |a 5-aza-2'-deoxycytine 
653 |a saponins 
653 |a phenolics 
653 |a cardiovascular disease 
653 |a antioxidant 
653 |a colorectal cancer 
653 |a trypsin inhibitors 
653 |a seeds 
653 |a green tea 
653 |a Gac 
653 |a randomized clinical trial 
653 |a melanoma 
653 |a adverse events 
653 |a extraction 
653 |a microbiome 
653 |a Momordica cochinchinensis 
653 |a freeze dried extract 
653 |a renal cell carcinoma 
653 |a methylation 
653 |a cancer 
653 |a probiotics 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/1565  |7 0  |z Get Fullteks 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/54350  |7 0  |z DOAB: description of the publication